Home › NDC Lookup › Labelers › Biocon Biologics Inc.

Biocon Biologics Inc. NDCs and Package Codes

This page lists NDC package records associated with labeler code 83257 (Biocon Biologics Inc.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

27
Package NDCs
55
Products
54
Active listings
1
Discontinued
10
Ingredients
0
Therapeutic classes
5
Dosage forms
7
With NADAC pricing

Portfolio

Top ingredients
ustekinumab 16
adalimumab-fkjp 9
trastuzumab-dkst 6
insulin glargine-yfgn 6
insulin aspart-xjhz 4
bevacizumab-nwgd 4
Denosumab-kyqq 4
pegfilgrastim-jmdb 2
water 2
aflibercept-jbvf 2
By dosage form
INJECTION, SOLUTION 26
KIT 11
INJECTION 10
INJECTION, POWDER, LYOPHILIZED, FO... 4
SOLUTION 4

Browse records — 55 products

Drug / product Billing NDC NADAC / unit Status
Adalimumab KIT Biocon · NDC 83257-0021-42 · 2 TRAY in 1 KIT (83257-021-42) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT / 1 mL in 1 PACKET 83257-0021-42 — On market View →
Adalimumab KIT Biocon · NDC 83257-0020-42 · 2 TRAY in 1 KIT (83257-020-42) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE * 2 PACKET in 1 KIT / 1 mL in 1 PACKET 83257-0020-42 — On market View →
Adalimumab KIT Biocon · NDC 83257-0022-32 · 2 TRAY in 1 KIT (83257-022-32) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT / 1 mL in 1 PACKET 83257-0022-32 — On market View →
Adalimumab KIT Biocon · NDC 83257-0020-42 · 2 TRAY in 1 KIT (83257-020-42) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE * 2 PACKET in 1 KIT / 1 mL in 1 PACKET 83257-0020-42 — On market View →
Adalimumab KIT Biocon · NDC 83257-0021-42 · 2 TRAY in 1 KIT (83257-021-42) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT / 1 mL in 1 PACKET 83257-0021-42 — On market View →
Adalimumab KIT Biocon · NDC 83257-0022-32 · 2 TRAY in 1 KIT (83257-022-32) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT / 1 mL in 1 PACKET 83257-0022-32 — On market View →
AUKELSO Denosumab-kyqq 120 mg/1.7mL INJECTION Biocon · NDC 83257-0030-11 · 1 VIAL, SINGLE-USE in 1 CARTON (83257-030-11) / 1.7 mL in 1 VIAL, SINGLE-USE 83257-0030-11 — On market View →
AUKELSO Denosumab-kyqq 120 mg/1.7mL INJECTION Biocon · NDC 83257-0030-11 · 1 VIAL, SINGLE-USE in 1 CARTON (83257-030-11) / 1.7 mL in 1 VIAL, SINGLE-USE 83257-0030-11 — On market View →
BOSAYA Denosumab-kyqq 60 mg/mL INJECTION Biocon · NDC 83257-0029-41 · 1 SYRINGE in 1 CARTON (83257-029-41) / 1 mL in 1 SYRINGE 83257-0029-41 — On market View →
BOSAYA Denosumab-kyqq 60 mg/mL INJECTION Biocon · NDC 83257-0029-41 · 1 SYRINGE in 1 CARTON (83257-029-41) / 1 mL in 1 SYRINGE 83257-0029-41 — On market View →
Fulphila pegfilgrastim-jmdb 6 mg/.6mL INJECTION Biocon · NDC 83257-0005-41 · Q5108 · 1 SYRINGE in 1 CARTON (83257-005-41) / .6 mL in 1 SYRINGE 83257-0005-41 $3,185.940 /unit · NADAC On market View →
Fulphila pegfilgrastim-jmdb 6 mg/.6mL INJECTION Biocon · NDC 83257-0005-41 · Q5108 · 1 SYRINGE in 1 CARTON (83257-005-41) / .6 mL in 1 SYRINGE 83257-0005-41 $3,185.940 /unit · NADAC On market View →
HULIO adalimumab-fkjp KIT Biocon · NDC 83257-0016-42 · 2 TRAY in 1 KIT (83257-016-42) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE * 2 PACKET in 1 KIT / 1 mL in 1 PACKET 83257-0016-42 — On market View →
HULIO adalimumab-fkjp KIT Biocon · NDC 83257-0019-32 · 2 TRAY in 1 KIT (83257-019-32) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT / 1 mL in 1 PACKET 83257-0019-32 — On market View →
HULIO adalimumab-fkjp KIT Biocon · NDC 83257-0017-42 · 2 TRAY in 1 KIT (83257-017-42) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT / 1 mL in 1 PACKET 83257-0017-42 — Discontinued View →
INSULIN DILUTING MEDIUM FOR Kirsty water 1 mL/mL INJECTION, SOLUTION Biocon · NDC 83257-0006-11 · 1 VIAL, MULTI-DOSE in 1 CARTON (83257-006-11) / 10 mL in 1 VIAL, MULTI-DOSE 83257-0006-11 — On market View →
INSULIN DILUTING MEDIUM FOR Kirsty water 1 mL/mL INJECTION, SOLUTION Biocon · NDC 83257-0006-11 · 1 VIAL, MULTI-DOSE in 1 CARTON (83257-006-11) / 10 mL in 1 VIAL, MULTI-DOSE 83257-0006-11 — On market View →
Insulin Glargine 100 [iU]/mL INJECTION, SOLUTION Biocon · NDC 83257-0014-11 · 1 VIAL, MULTI-DOSE in 1 CARTON (83257-014-11) / 10 mL in 1 VIAL, MULTI-DOSE 83257-0014-11 $6.086 /unit · NADAC On market View →
Insulin Glargine 100 [iU]/mL INJECTION, SOLUTION Biocon · NDC 83257-0015-31 · 1 SYRINGE in 1 CARTON (83257-015-31) / 3 mL in 1 SYRINGE 83257-0015-31 — On market View →
Insulin Glargine 100 [iU]/mL INJECTION, SOLUTION Biocon · NDC 83257-0014-11 · 1 VIAL, MULTI-DOSE in 1 CARTON (83257-014-11) / 10 mL in 1 VIAL, MULTI-DOSE 83257-0014-11 $6.086 /unit · NADAC On market View →
Insulin Glargine 100 [iU]/mL INJECTION, SOLUTION Biocon · NDC 83257-0015-31 · 1 SYRINGE in 1 CARTON (83257-015-31) / 3 mL in 1 SYRINGE 83257-0015-31 — On market View →
JOBEVNE bevacizumab-nwgd 25 mg/mL INJECTION Biocon · NDC 83257-0009-11 · Q5160 · 1 VIAL, SINGLE-DOSE in 1 CARTON (83257-009-11) / 4 mL in 1 VIAL, SINGLE-DOSE 83257-0009-11 — On market View →
JOBEVNE bevacizumab-nwgd 25 mg/mL INJECTION Biocon · NDC 83257-0010-11 · Q5160 · 1 VIAL, SINGLE-DOSE in 1 CARTON (83257-010-11) / 16 mL in 1 VIAL, SINGLE-DOSE 83257-0010-11 — On market View →
JOBEVNE bevacizumab-nwgd 25 mg/mL INJECTION Biocon · NDC 83257-0009-11 · Q5160 · 1 VIAL, SINGLE-DOSE in 1 CARTON (83257-009-11) / 4 mL in 1 VIAL, SINGLE-DOSE 83257-0009-11 — On market View →
JOBEVNE bevacizumab-nwgd 25 mg/mL INJECTION Biocon · NDC 83257-0010-11 · Q5160 · 1 VIAL, SINGLE-DOSE in 1 CARTON (83257-010-11) / 16 mL in 1 VIAL, SINGLE-DOSE 83257-0010-11 — On market View →
KIRSTY insulin aspart-xjhz 100 [iU]/mL INJECTION, SOLUTION Biocon · NDC 83257-0008-32 · 5 SYRINGE in 1 CARTON (83257-008-32) / 3 mL in 1 SYRINGE (83257-008-31) 83257-0008-32 — On market View →
KIRSTY insulin aspart-xjhz 100 [iU]/mL INJECTION, SOLUTION Biocon · NDC 83257-0007-11 · 1 VIAL, MULTI-DOSE in 1 CARTON (83257-007-11) / 10 mL in 1 VIAL, MULTI-DOSE 83257-0007-11 — On market View →
KIRSTY insulin aspart-xjhz 100 [iU]/mL INJECTION, SOLUTION Biocon · NDC 83257-0008-32 · 5 SYRINGE in 1 CARTON (83257-008-32) / 3 mL in 1 SYRINGE (83257-008-31) 83257-0008-32 — On market View →
KIRSTY insulin aspart-xjhz 100 [iU]/mL INJECTION, SOLUTION Biocon · NDC 83257-0007-11 · 1 VIAL, MULTI-DOSE in 1 CARTON (83257-007-11) / 10 mL in 1 VIAL, MULTI-DOSE 83257-0007-11 — On market View →
OGIVRI trastuzumab-dkst 150 mg/7.4mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Biocon · NDC 83257-0001-11 · Q5114 · 1 VIAL in 1 CARTON (83257-001-11) / 15 mL in 1 VIAL 83257-0001-11 — On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.